Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India
- PMID: 28756826
- PMCID: PMC7320448
- DOI: 10.1016/j.jegh.2017.05.002
Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India
Abstract
Data regarding prevalence of multi-drug resistant tuberculosis (MDR-TB) and associated common mutations is scarce from Punjab region. The study was designed to determine rate of MDR-TB among presumptive MDR-TB from Punjab and mutation patterns using GenoType MTBDRplus assay. Total of 812 consecutive sputum samples were received from January 2012 to July 2013, from 14 districts of Punjab at the National Reference Laboratory at New Delhi for diagnosis of MDR-TB as hand holding activity. Presumptive MDR-TB patients were identified on basis of criterion B defined by the programme. Smear positive and negatives patients were found to be 636/798 (79.7%) and 162/ 798 (20.3%) respectively. Total of 606 GenoType MTBDRplus tests were conducted and mutations in rpoB, kat G and inhA genes analyzed. Total of 94/606 (15.5%), 43/606 (7.1%) and 40/606 (6.6%) were found to be RIF and INH resistant, mono-RIF resistant and 40/606 (6.6%) mono-INH resistant respectively. Commonest known mutation for RIF in rpoB gene and INH in kat G gene was S531L (80/ 137; 58.4%) and S315T1 (119/134; 88.8%) respectively. Mutations in inhA were found in 21/134 (15.7%) strains. Average turn-around time (TAT) for dispatch of result toPunjab was 4.6days. Prevalence of RIF resistance in Punjab was found to be 22.6%. Common mutations for RIF and INH were similar to that in other regions of country. GenoType MTBDRplus was found to be useful assay for rapid detection of MDR-TB, responsible for determining better management of MDR-TB patients under the programme.
Keywords: Genotype MTBDRplus; MDR suspect; Mutation.
Copyright © 2017. Published by Elsevier Ltd.
Figures
Similar articles
-
Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay.Indian J Med Microbiol. 2015 Feb;33 Suppl:46-52. doi: 10.4103/0255-0857.150879. Indian J Med Microbiol. 2015. PMID: 25657156
-
Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.BMC Infect Dis. 2017 May 31;17(1):379. doi: 10.1186/s12879-017-2489-3. BMC Infect Dis. 2017. PMID: 28569148 Free PMC article.
-
Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.Indian J Med Res. 2014 Oct;140(4):501-6. Indian J Med Res. 2014. PMID: 25488443 Free PMC article.
-
Multidrug-resistant tuberculosis.Clin Chim Acta. 2024 Jun 1;559:119701. doi: 10.1016/j.cca.2024.119701. Epub 2024 May 1. Clin Chim Acta. 2024. PMID: 38697459 Review.
-
How do Mutations of Mycobacterium Genes Cause Drug Resistance in Tuberculosis?Curr Pharm Biotechnol. 2024;25(6):724-736. doi: 10.2174/0113892010257816230920053547. Curr Pharm Biotechnol. 2024. PMID: 37888812 Review.
Cited by
-
Heteroresistance to rifampicin & isoniazid in clinical samples of patients with presumptive drug-resistant tuberculosis in Central India.Indian J Med Res. 2023 Feb-Mar;157(2&3):174-182. doi: 10.4103/ijmr.ijmr_607_22. Indian J Med Res. 2023. PMID: 37202936 Free PMC article.
-
Antibiotic heteroresistance in Mycobacterium tuberculosis isolates: a systematic review and meta-analysis.Ann Clin Microbiol Antimicrob. 2021 Oct 13;20(1):73. doi: 10.1186/s12941-021-00478-z. Ann Clin Microbiol Antimicrob. 2021. PMID: 34645463 Free PMC article.
-
Study of the prevalence of Multidrug-Resistant Pulmonary Tuberculosis (MDR-TB) in Western Rajasthan using line probe assay.J Family Med Prim Care. 2020 Feb 28;9(2):1093-1097. doi: 10.4103/jfmpc.jfmpc_916_19. eCollection 2020 Feb. J Family Med Prim Care. 2020. PMID: 32318473 Free PMC article.
-
Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.Nat Commun. 2018 Oct 8;9(1):4147. doi: 10.1038/s41467-018-06587-2. Nat Commun. 2018. PMID: 30297823 Free PMC article.
-
Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis.Infect Dis Poverty. 2023 May 25;12(1):57. doi: 10.1186/s40249-023-01107-x. Infect Dis Poverty. 2023. PMID: 37231463 Free PMC article.
References
-
- World Health Organization . TB Geneva, Switzerland: 2016. Global tuberculosis report: WHO Report 2016 WHO/HTM/. Available at: http: www.who.int/tb/publications/global_report/11.
-
- World Health Organization . TB Geneva, Switzerland: 2008. Policy statement; Molecular line probe assays for rapid screening of patients at risk of multi drug resistant tuberculosis (MDR-TB): WHO Report 2008 WHO/HTM/ Available at: http: www.who.int/tb/features_archive/policy_statement.
-
- Brossier F, Veziris N, Pernot CT, Jarlier V, Sougakoff W. Performance of the GenoType MTBDR line probe assay for detection of resistance to rifampicin and isoniazid in strains of Mycobacterium tuberculosis with low and high level resistance. J Clin Microbiol. 2006;44(10):3659–64. doi: 10.1128/jcm.01054-06. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases